IP Library Granted Patent US 9,351,930
Granted Patent B2
US 9,351,930 · App. 13/494,815 · Granted May 31, 2016

Antibiotic formulations, unit doses, kits, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,351,930
App. No.
13/494,815
Granted
May 31, 2016
Kind
B2
Abstract

An aqueous or powder composition includes anti-gram-negative antibiotic or salt thereof being present at an amount ranging from about 100 mg/ml to about 200 mg/ml. Another aqueous or powder composition includes anti-gram-positive antibiotic or salt thereof being present at a concentration ranging from about 0.6 to about 0.9 of the water solubility limit, at 25° C. and 1.0 atmosphere, of the anti-gram-positive antibiotic or salt thereof. Other embodiments include unit doses, kits, and methods.

Claims (7)

1. A kit comprising:

a unit dose comprising about 3 to 10 ml of a preservative-free liquid composition for aerosolization having a pH of about 5.5 to about 6.3 and a shelf life of at least two years at room temperature without the formation of precipitate, wherein the composition consists essentially of water and about 400 mg to about 750 mg amikacin, at a concentration of about 125 mg/ml;

wherein the composition has an osmolarity ranging from about 90 mOsmol/kg to about 500 mOsmol/kg and a potency of amikacin, from about 500 μg/mg to about 1100 μg/mg; and

a vibrating mesh nebulizer.

2. A unit dose comprising:

about 3 to 10 ml of a preservative-free liquid composition for aerosolization having a pH of about 5.5 to about 6.3 and a shelf life of at least two years at room temperature without the formation of precipitate, wherein the composition consists essentially of water and about 400 mg to about 750 mg amikacin, at a concentration of about 125 mg/ml;

wherein the composition has an osmolarity ranging from about 90 mOsmol/kg to about 500 mOsmol/kg and a potency of amikacin, from about 500 μg/mg to about 1100 μg/mg.

Assignments (3)
CONFIRMATORY ASSIGNMENT Recorded Oct 30, 2015
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 037010/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2013
From: CHARAN, CHATAN; DWIVEDI, SARVAJNA
To: NEKTAR THERAPEUTICS
Reel/Frame 031443/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2013
From: NEKTAR THERAPEUTICS
To: BAYER HEALTHCARE AG
Reel/Frame 031443/0950 →